Analyst firms · BofA Securities · FGEN

BofA Securities FGEN price target and rating history

FibroGen Inc (FGEN) · Health Care

BofA Securities rates FibroGen Inc (FGEN) Underperform with a $2 price target, as of its latest action on Aug 8, 2023. It has published 4 rating actions on FGEN since July 2021, including 1 upgrade and 3 downgrades.

Current rating
Underperform
Price target
$2
Median target, all firms
Too few
Actions on FGEN
4

BofA Securities price target on FGEN

$4.14$3.07$220222023202420252026
BofA Securities price target on FGEN, each point a stated target, July 2021 to August 2023. Targets before August 2023 (divided by 7) are adjusted for a stock split, going by the prior target BofA Securities restated.

Every BofA Securities rating on FGEN

Questions about BofA Securities and FGEN

What is BofA Securities's price target for FGEN?
BofA Securities's latest stated price target for FibroGen Inc (FGEN) is $2, from its action on Aug 8, 2023.
What is BofA Securities's rating on FGEN?
BofA Securities rates FGEN Underperform, a bearish rating, as of Aug 8, 2023.
When did BofA Securities last change its view on FGEN?
On Aug 8, 2023, BofA Securities downgrades to Underperform from Neutral, price target $4 to $2.

More FGEN rating histories

All BofA Securities ratingsFGEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.